Skip to content

13F-HR filed by Corriente Advisors, LLC

Corriente Advisors, LLC filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-18, with 10 holding rows worth $271,579,000.

Accession
0001085146-21-001809
Filed
2021-05-18
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2021

A holdings report, 10 entries on the cover page, a total value of $271,579,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $271,579,000 with VALUE read as thousands by filing date, 13F file number 028-12875. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
MAXAR TECHNOLOGIES INC57778K105COM2,650,000$100,223,000thousands by filing date
REPLIMUNE GROUP INC76029N106COMMON STOCK1,075,000$32,798,000thousands by filing date
CUE BIOPHARMA INC22978P106COM2,549,031$31,098,000thousands by filing date
CARDIFF ONCOLOGY INC14147L108COM2,785,410$25,793,000thousands by filing date
TELEDYNE TECHNOLOGIES INC COM879360105Stock55,000$22,751,000thousands by filing date
TFF PHARMACEUTICALS INC87241J104COM1,565,682$21,246,000thousands by filing date
META PLATFORMS INC CL A30303M102COM50,000$14,727,000thousands by filing date
LANTERN PHARMA INC51654W101COM713,806$12,948,000thousands by filing date
DIAMEDICA THERAPEUTICS INC25253X207COMMON STOCK870,228$7,963,000thousands by filing date
EYEPOINT INC COM NEW30233G209Stock200,000$2,032,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001085146-21-001809this filing2021-05-18acceptance time not in the bulk data set